<DOC>
	<DOC>NCT01070615</DOC>
	<brief_summary>Objectives: Evaluation of the clinical long-term safety, tolerability, patient satisfaction, pharmacokinetics and pattern of use of oral prucalopride tablets given in doses up to 4 mg once daily to patients with chronic constipation</brief_summary>
	<brief_title>Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>1. Male or nonpregnant, nonbreastfeeding female outpatients of at least 18 years of age 2. Patient had completed the entire treatment period of the PRUINT6 study or the PRUINT12 study . 1. Patients with impaired renal function 2. Patients with clinically significant abnormalities of haematology, urinalysis, or blood chemistry. 3. Females of childbearing potential without adequate contraceptive protection during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>